ATE334590T1 - Anti-arrhythmische zusammensetzungen und behandlungsverfahren - Google Patents

Anti-arrhythmische zusammensetzungen und behandlungsverfahren

Info

Publication number
ATE334590T1
ATE334590T1 AT03000103T AT03000103T ATE334590T1 AT E334590 T1 ATE334590 T1 AT E334590T1 AT 03000103 T AT03000103 T AT 03000103T AT 03000103 T AT03000103 T AT 03000103T AT E334590 T1 ATE334590 T1 AT E334590T1
Authority
AT
Austria
Prior art keywords
arrhythmic
compositions
treatment methods
treatment
cardiac arrhythmia
Prior art date
Application number
AT03000103T
Other languages
English (en)
Inventor
Raymond J Bergeron Jr
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of ATE334590T1 publication Critical patent/ATE334590T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT03000103T 1997-06-04 1998-06-03 Anti-arrhythmische zusammensetzungen und behandlungsverfahren ATE334590T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/868,941 US6083991A (en) 1997-06-04 1997-06-04 Anti-arrhythmic composition and methods of treatment

Publications (1)

Publication Number Publication Date
ATE334590T1 true ATE334590T1 (de) 2006-08-15

Family

ID=25352608

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03000103T ATE334590T1 (de) 1997-06-04 1998-06-03 Anti-arrhythmische zusammensetzungen und behandlungsverfahren
AT98925149T ATE334589T1 (de) 1997-06-04 1998-06-03 Anti-arrhythmische zusammensetzungen und behandlungsverfahren

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98925149T ATE334589T1 (de) 1997-06-04 1998-06-03 Anti-arrhythmische zusammensetzungen und behandlungsverfahren

Country Status (11)

Country Link
US (2) US6083991A (de)
EP (3) EP1006793B1 (de)
JP (1) JP3410109B2 (de)
KR (1) KR100372243B1 (de)
AT (2) ATE334590T1 (de)
AU (1) AU738742B2 (de)
CA (1) CA2293265A1 (de)
DE (2) DE69835461D1 (de)
NO (1) NO995944L (de)
NZ (2) NZ511576A (de)
WO (1) WO1998054962A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083991A (en) 1997-06-04 2000-07-04 University Of Florida Research Foundation, Inc. Anti-arrhythmic composition and methods of treatment
US7414112B2 (en) 1998-10-08 2008-08-19 Genentech, Inc. Antibodies to PRO1550 polypeptides
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
US6500457B1 (en) 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
US6458795B1 (en) * 2001-11-15 2002-10-01 University Of Florida Method and composition for treatment of irritable bowel disease
US20040138306A1 (en) * 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
US20060281820A1 (en) * 2003-02-19 2006-12-14 Kuniyasu Soda Lfa-1 inhibitors and use thereof
WO2005041988A1 (en) * 2003-10-22 2005-05-12 University Of Florida Method and composition for pain amelioration
EP1762179A1 (de) * 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Methode zur Verbesserung der Qualität der Diagnostik in der Echokardiographie
TWI519298B (zh) 2008-04-17 2016-02-01 賽諾菲 安萬特公司 決奈達隆（ｄｒｏｎｅｄａｒｏｎｅ）於製備用於預防心血管疾病住院或死亡之藥劑之用途
FR2930149B1 (fr) * 2008-04-17 2011-02-18 Sanofi Aventis Association de dronedarone avec au moins un diuretique, son application en therapeutique
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
MX2014001556A (es) 2011-08-12 2014-03-31 Boehringer Ingelheim Vetmed Composicion farmaceutica de sabor enmascarado.

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB235752A (en) 1924-08-30 1925-06-25 Jean Emile Oddon Improvements relating to steam generators
GB300908A (en) 1927-11-19 1929-08-08 Antoine Padoue Filippi Ships with lifting devices rotating by auto-gyration
GB307121A (en) 1927-12-09 1929-03-07 English Electric Co Ltd Improvements in the regulation of asynchronous alternating current machines
GB397121A (en) 1932-02-15 1933-08-15 Tabulating Machine Co Improvements in or relating to record-card-controlled statistical machines
GB1339764A (en) * 1971-03-29 1973-12-05 Ici Ltd Pyridine derivatives
US4806555A (en) 1974-10-25 1989-02-21 A. H. Robins Company, Incorporated 1-aryloxy-4-amino-2-butanols
US4544654A (en) 1984-03-20 1985-10-01 Schering A.G. Substituted sulfonamidobenzamides, antiarrhythmic agents and compositions thereof
US5128353A (en) 1985-06-20 1992-07-07 University Of Florida Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment
US5173505A (en) 1985-06-20 1992-12-22 University Of Florida Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment
JPH0789414B2 (ja) 1986-01-31 1995-09-27 シャープ株式会社 光学記憶素子
GB8603120D0 (en) 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
PH23283A (en) 1986-02-26 1989-06-30 Eisai Co Ltd Piperidine derivative, pharmaceutical composition containing the same and method of use thereof
GB8609630D0 (en) 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
GB8619472D0 (en) 1986-08-09 1986-09-17 Pfizer Ltd Anti-arrhythmia agents
DE3633977A1 (de) 1986-10-06 1988-04-07 Cassella Ag Tetrahydrochinolinderivate, ein verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen
US5091576A (en) * 1986-12-02 1992-02-25 University Of Florida Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US5342945A (en) 1986-12-02 1994-08-30 University Of Florida Research Foundation, Inc. Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US5393757A (en) 1986-12-02 1995-02-28 University Of Florida Polyamines and anti-diarrheal and gastrointestinal anti-spasmodic pharmaceutical compositions and methods of treatment
US4956382A (en) 1987-02-07 1990-09-11 Pfizer Inc. Sulfonamide anti-arrhythmic agents
GB8707120D0 (en) 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents
GB8707122D0 (en) 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents
GB8707121D0 (en) 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents
GB8718345D0 (en) 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides
US5118780A (en) 1989-05-12 1992-06-02 Kuraray Co., Ltd. Polyester urethane fiber: polyester made from methyl pentane diol
US5929039A (en) * 1993-11-15 1999-07-27 Baker Medical Research Institute Method for treating cardiac dysfunction and pharmaceutical compositions useful therefor
US5510390A (en) * 1994-01-28 1996-04-23 University Of Florida Research Foundation, Inc. Anti-hypertensive composition and methods of treatment
US5516807A (en) * 1994-10-25 1996-05-14 Warner-Lambert Company Method for treating vascular proliferative disorders following balloon angioplasty
US6083991A (en) 1997-06-04 2000-07-04 University Of Florida Research Foundation, Inc. Anti-arrhythmic composition and methods of treatment

Also Published As

Publication number Publication date
NO995944L (no) 2000-02-02
EP1006793A4 (de) 2002-10-09
EP1561462A3 (de) 2005-08-24
DE69835461D1 (de) 2006-09-14
EP1304108A3 (de) 2003-12-03
KR100372243B1 (ko) 2003-02-17
US6297287B1 (en) 2001-10-02
NZ511576A (en) 2005-03-24
WO1998054962A1 (en) 1998-12-10
JP3410109B2 (ja) 2003-05-26
AU738742B2 (en) 2001-09-27
DE69835435D1 (de) 2006-09-14
NO995944D0 (no) 1999-12-03
EP1304108A2 (de) 2003-04-23
EP1304108B1 (de) 2006-08-02
CA2293265A1 (en) 1998-12-10
EP1006793B1 (de) 2006-08-02
US6083991A (en) 2000-07-04
NZ501492A (en) 2002-09-27
JP2001508803A (ja) 2001-07-03
KR20010013230A (ko) 2001-02-26
AU7716598A (en) 1998-12-21
ATE334589T1 (de) 2006-08-15
EP1561462A2 (de) 2005-08-10
EP1006793A1 (de) 2000-06-14

Similar Documents

Publication Publication Date Title
CZ309247B6 (cs) 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
ATE334589T1 (de) Anti-arrhythmische zusammensetzungen und behandlungsverfahren
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
GB2285219B (en) Use of norastemizole for the treatment of allergic disorders
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
GEP20043162B (en) Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance
ES2136167T3 (es) Composiciones de idebenona para tratar la enfermedad de alzheimer.
GR3017855T3 (en) Use of lithium in the treatment or prophylaxis of Molluscum contagiosum.
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
GR3032224T3 (en) Therapeutic agent for threatened abortion.
CO5031290A1 (es) Formulacion lo
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
NO20010984D0 (no) Anvendelse av R(+)-<alfa>-(2,3-dimetoksyfenyl)-1-[2-(4- fluorfenyl)etyl]-4-piperidinmetanol for behandling av søvnforstyrrelser
EP0202986A3 (en) Use of "naftidrofuryl" in the treatment of neuropathies
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi
UA10335A (uk) Спосіб корекції порушеhь обміhу кальцію у хворих hа сиhдром рейтера хламідійhої етіології

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties